Guideline-recommended calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: Documentation patterns and bone outcomes in a real-world cohort.
614 Background: Men initiating androgen deprivation therapy (ADT) for prostate cancer face accelerated bone loss, and guidelines recommend calcium and vitamin D supplementation as baseline bone-protective care. Real-world documentation of this care, and its relationship to bone outcomes, is poorly characterized...